Erectile Dysfunction

"India is researching its way out of ill health." To make sure that remains the case, government regulation will probably be needed, the report concluded.

But other observers say the explosive growth predicted for the industry will help and not hurt health in developing countries.

The less restrictive government regulations in India, combined with the soaring number of scientists graduating each year, means that incentives to move research overseas are powerful, said Fariborz Ghadar, director of the Center for Global Business Studies at Penn State University.

Meanwhile, the changing economic landscape for drug development means that U.S.

and European companies are more likely to outsource research, and research firms need more help marketing the products they develop, he told UPI.

"Those kinds of alliances are basically everywhere." Given that growth, the Indian biotechnology sector will not need to choose between domestic health needs and the global marketplace, Ghadar said.

"I think the market's going to grow so rapidly in India that you're going to see all of the above." And if the country continues to graduate researchers at the same high rate, he said, "if anything, they're going to be hard-pressed to find jobs." Indian firms have also excelled at turning developing-country markets into sound busi...

Read more...